MENINGOCOCCAL IMMUNISATION
Clinical trials for MENINGOCOCCAL IMMUNISATION explained in plain language.
Never miss a new study
Get alerted when new MENINGOCOCCAL IMMUNISATION trials appear
Sign up with your email to follow new studies for MENINGOCOCCAL IMMUNISATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New meningitis vaccine shows promise in teen trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new meningitis vaccine (MenACYW) in 463 healthy adolescents aged 10-17. It compared the new vaccine to an existing one (Nimenrix®) and also checked safety when given alongside HPV and Tdap-IPV vaccines. The goal was to see if the new vaccine provides similar p…
Matched conditions: MENINGOCOCCAL IMMUNISATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:54 UTC
-
Booster shot study shows promise in protecting toddlers from deadly infection
⭐️ VACCINE ⭐️ CompletedThis study looked at whether a booster shot of the MenQuadfi vaccine is safe and effective for toddlers aged 12 to 23 months who had already received a meningococcal vaccine as babies. The goal was to see if the booster could strengthen their protection against a serious bacteria…
Matched conditions: MENINGOCOCCAL IMMUNISATION
Phase: PHASE4 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:38 UTC
-
New meningitis vaccine shows promise in protecting babies
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine to protect infants and toddlers against four types of meningococcal bacteria that can cause meningitis. Over 1,500 healthy children in India and South Africa received the vaccine alongside their routine shots. Researchers checked if the vaccine tri…
Matched conditions: MENINGOCOCCAL IMMUNISATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 08, 2026 12:01 UTC
-
New meningitis vaccine shows promise for infants in major trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new meningitis vaccine (MenACYW) in 840 healthy infants and toddlers. Participants received two doses at 6 and 12 months old. The goal was to see if the new vaccine works as well as an existing vaccine (Nimenrix) and is safe. The study is complete and aims to …
Matched conditions: MENINGOCOCCAL IMMUNISATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 30, 2026 15:51 UTC
-
New 5-in-1 meningitis vaccine shows promise in large trial
⭐️ VACCINE ⭐️ CompletedThis study tested an experimental vaccine designed to protect against five strains of meningococcal bacteria (A, B, C, W, Y), which can cause serious infections like meningitis. About 1,200 healthy adolescents and young adults received the vaccine to check its safety and how well…
Matched conditions: MENINGOCOCCAL IMMUNISATION
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 26, 2026 20:00 UTC